Cargando…

Editorial: New Advances in Cardiorenal Syndrome

Detalles Bibliográficos
Autores principales:	Calvier, Laurent, Kökény, Gábor, Martinez-Martinez, Ernesto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331892/ https://www.ncbi.nlm.nih.gov/pubmed/35911551 http://dx.doi.org/10.3389/fcvm.2022.976846

Ejemplares similares

Cardiorenal syndrome and diabetes: an evil pairing
por: Méndez Fernández, Ana Belén, et al.
Publicado: (2023)

Toward Human Models of Cardiorenal Syndrome in vitro
por: Gabbin, Beatrice, et al.
Publicado: (2022)

Immunomodulatory Approaches in Diabetes-Induced Cardiorenal Syndromes
por: Ammar, Lama A., et al.
Publicado: (2021)

Mitochondrial Dysfunction: An Emerging Link in the Pathophysiology of Cardiorenal Syndrome
por: Shi, Shuqing, et al.
Publicado: (2022)

Biomarkers in Cardiorenal Syndrome and Potential Insights Into Novel Therapeutics
por: Chung, Edmund Y. M., et al.
Publicado: (2022)

Chronic Secondary Cardiorenal Syndrome: The Sixth Innovative Subtype
por: Zhang, Yipeng, et al.
Publicado: (2021)

Cardiorenal Syndrome in COVID-19 Patients: A Systematic Review
por: Lin, Ling, et al.
Publicado: (2022)

PPARγ and TGFβ—Major Regulators of Metabolism, Inflammation, and Fibrosis in the Lungs and Kidneys
por: Kökény, Gábor, et al.
Publicado: (2021)

Insights of Worsening Renal Function in Type 1 Cardiorenal Syndrome: From the Pathogenesis, Biomarkers to Treatment
por: Fu, Kang, et al.
Publicado: (2021)

Estimated plasma volume status: association with congestion, cardiorenal syndrome and prognosis in precapillary pulmonary hypertension
por: Yogeswaran, Athiththan, et al.
Publicado: (2023)

Tricuspid regurgitation, right ventricular function, and renal congestion: a cardiorenal triangle
por: Forado-Benatar, Ilana, et al.
Publicado: (2023)

Mechanisms of Cardiorenal Protection With SGLT2 Inhibitors in Patients With T2DM Based on Network Pharmacology
por: Wang, Anzhu, et al.
Publicado: (2022)

Meta-Analysis on the Safety and Cardiorenal Efficacy of SGLT2 Inhibitors in Patients Without T2DM
por: Li, Lu-Feng, et al.
Publicado: (2021)

Editorial: New insights in heart valve disease 2022
por: Greco, Ernesto, et al.
Publicado: (2023)

The PPARγ agonist pioglitazone prevents TGF-β induced renal fibrosis by repressing EGR-1 and STAT3
por: Németh, Ágnes, et al.
Publicado: (2019)

Fibrosis, the Bad Actor in Cardiorenal Syndromes: Mechanisms Involved
por: Delgado-Valero, Beatriz, et al.
Publicado: (2021)

The prevalence of cardiorenal anemia syndrome among patients with heart failure and its association with all-cause hospitalizations: a retrospective single-center study from the Middle East
por: Manla, Yosef, et al.
Publicado: (2023)

Editorial: Advances in Intravascular Imaging
por: Bourantas, Christos V., et al.
Publicado: (2021)

Editorial: Advances in aortic imaging
por: Leach, Joseph R., et al.
Publicado: (2023)

Editorial: Advances in thrombin generation
por: de Laat-Kremers, Romy, et al.
Publicado: (2023)

Editorial: Advanced research on abdominal and thoracic aortic aneurysms: new insights into molecular mechanisms
por: Subramanian, Venkateswaran, et al.
Publicado: (2023)

Editorial: Multicellularity in the Cardiovascular System
por: Madeddu, Paolo, et al.
Publicado: (2019)

Editorial: Advances in Percutaneous Coronary Intervention
por: Silverio, Angelo, et al.
Publicado: (2022)

New Advances in Cardiorenal Syndrome—Ready for Prime Time?
por: Pliquett, Rainer U.
Publicado: (2022)

Editorial: Advances in understanding the mechanisms of pulmonary hypertension
por: Ahmad, Ashfaq, et al.
Publicado: (2023)

Editorial: Advanced echocardiographic techniques in structural heart intervention
por: Wong, Randolph H. L., et al.
Publicado: (2022)

Editorial: Gaps, priorities, and advances in cardiovascular medicine in Africa
por: Kruger, Ruan, et al.
Publicado: (2023)

Editorial: Advances in cardiac imaging and heart failure management
por: Mandoli, Giulia Elena, et al.
Publicado: (2023)

Does Combination Therapy With SGLT2 Inhibitors and Renin–Angiotensin System Blockers Lead to Greater Reduction in Cardiorenal Events Among Patients With Type 2 Diabetes?
por: Zhao, Li-Min, et al.
Publicado: (2021)

Editorial: Venous thromboembolism and pregnancy
por: Tardy, Bernard, et al.
Publicado: (2022)

Editorial: Advances and challenges in remote monitoring of patients with heart failure
por: Perl, Leor, et al.
Publicado: (2022)

Editorial: Long-term perspectives in advanced heart failure therapies
por: Schoenrath, Felix, et al.
Publicado: (2023)

Editorial: Multimodality Imaging in Acute Coronary Syndrome
por: Wang, Yining, et al.
Publicado: (2022)

Editorial: The Role of Sex in Heart Failure and Transplantation
por: Martínez-Sellés, Manuel, et al.
Publicado: (2021)

Cardiorenal Syndrome: An Unsolved Clinical Problem
por: Martínez-Santos, Paula, et al.
Publicado: (2011)

Editorial: Contribution of Uremic Compounds to Cardiorenal Syndrome Development
por: Carneiro-Ramos, Marcela Sorelli, et al.
Publicado: (2022)

Editorial: Cardiovascular Fibrosis and Related Diseases: Basic and Clinical Research Advances
por: Bei, Yihua, et al.
Publicado: (2022)

Editorial: Advances in the Prevention and Rehabilitation of Cardiovascular Diseases via Aerobic Exercise
por: Cao, Richard Y., et al.
Publicado: (2022)

Editorial: Advances in the imaging and treatment of valvular heart disease: “rising to the challenge”
por: Banovic, Marko, et al.
Publicado: (2023)

Editorial: Insulin Resistance, Metabolic Syndrome, and Cardiovascular Disease
por: Yan, Tong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mdv3le54vbpkb2dtnkb2nnjh10